Seapharma Pharmaceutical Industries is considered one of the leading and new companies in the field of pharmaceutical industries. It is a joint venture, occupying an area of 60,000 m 2, and the areas of production departments are 5,000 m 2.
Production began in 2018, and the company launched quality and distinctive products that met the needs of the local market, in terms of both quantity and quality, and were introduced to the world market by exporting to different countries.
Seapharma is still in the process of introducing new distinguished products in different pharmaceutical forms. Seapharma has taken care to secure the delivery of its products to the consumer in any location, through an integrated distribution network and according to an accurate system that makes the company's products available permanently.
Seapharma Pharmaceutical Industries is committed to producing high quality human medications according to current Good Manufacturing Practices (cGMP) requirements for the implementation of a better healthy life for people, also Seapharma is committed to saving the environment and preventing its pollution, in addition to providing an ideal work environment for the employees and preventing work accidents through following occupational health and safety regulations.
Seapharma Pharmaceutical Industries strives to become one of the best companies locally, regionally and globally to reach new markets and provide specific medications with best specifications.